Riskpilot← Back to searchSign inGet full accessReomics AB
ABActiveOrg 5569079840Roslagsgatan 33 ASecurity and commodity contracts brokerage · NACE 6612Est. 20121 employees
Revenue 2025
SEK 124K
+22% vs 2024
EBITDA margin
-27.4%
+24% vs 2024
Equity ratio
84.0%
Financial strength
Net profit 2025
SEK 1,9M
+682% vs 2024
| Revenue | SEK 124K | +22% |
| EBITDA | SEK -34K | +24% |
| Net profit | SEK 1,9M | +682% |
| Total assets | SEK 8,6M | +19% |
| Equity | SEK 7,2M | +29% |
| Employees | 1 | — |
Legal name
Reomics AB
Org number
5569079840
Legal form
Aktiebolag
NACE code
6612 · Security and commodity contracts brokerage
Founded
25 oktober 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom lifescience, medical device, diagnostik och läkemedelsområdet på internationell bas i Europa, USA och Asien samt därmed förenlig verksamhet.
Address
Roslagsgatan 33 A
Email
rolf.ehrnstrom@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 158 | 2 334 | 1 798 | 923 | 627 | 145 | 102 | 124 |
| Staff expenses | — | — | — | — | — | — | −8 | — | — | — |
| EBITDA | 1 596 | 1 548 | 1 776 | 1 983 | 1 593 | 715 | 459 | −56 | −45 | −34 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | −210 | −0 |
| EBIT | 1 596 | 1 548 | 1 776 | 1 983 | 1 593 | 715 | 459 | −56 | −255 | −34 |
| Net financials | −1 | −3 | 114 | 41 | 37 | 56 | −249 | 266 | −642 | 1 672 |
| Profit before tax | 1 194 | 1 165 | 1 450 | 1 604 | 1 476 | 641 | 380 | 751 | −237 | 1 942 |
| Tax | −271 | −258 | −293 | −303 | −319 | −138 | −221 | −74 | −81 | −90 |
| Net profit | 923 | 907 | 1 157 | 1 301 | 1 157 | 503 | 159 | 677 | −318 | 1 852 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 269 | 4 276 | 5 566 | 6 938 | 7 813 | 8 056 | 7 832 | 8 100 | 7 214 | 8 562 |
| Equity | 1 886 | 2 643 | 3 600 | 4 551 | 5 308 | 5 627 | 5 589 | 6 072 | 5 554 | 7 192 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 |
| Short-term debt | 423 | 293 | 186 | 185 | 133 | 39 | 23 | 68 | 20 | 35 |
| Total debt | 423 | 293 | 186 | 185 | 133 | 39 | 23 | 68 | 20 | 35 |
EBITDA margin
-27.4%
This company
15.8%
Market median
-273% vs market
20162025
Equity ratio
84.0%
This company
38.2%
Market median
+120% vs market
20162025
Return on equity
25.8%
This company
18.4%
Market median
+40% vs market
20162025
Net profit margin
1493.5%
This company
8.1%
Market median
+18338% vs market
20162025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20162025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-10-01 – 2016-09-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Reomics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Elise Landers | Deputy Board Member | 0 companies |
| Rolf Bertil Ehrnström | Board of Directors | 0 companies |